Proinflammatory cytokine production by human peripheral blood mononuclear cells stimulated with cell-free supernatants of viridans streptococci

Cytokine

Volumn 8, Issue 4, 1996, Pages 300-304

  Soto, Alicia ^a   Evans, Thomas J ^a   Cohen, Jonathan ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

ARDS; IL 8; PBMC; TNF .TNF ; VS bacteraemia

Indexed keywords

CYTOKINE; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; CELL STIMULATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0029925297     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0040     Document Type: Article

References (34)

1. Crass BA, Bergdoll MS (1986) Toxin involvement in toxic shock syndrome. J Infect Dis 153:918-926.
2. Parsonnet J (1989) Mediators in the pathogenesis of toxic shock syndrome: Overview. Rev Infect Dis 11 (Suppl. 1):S263-S269.
3. Bone RC. (1993) Gram negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev 6:57-68.
4. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778.
5. Jupin C, Anderson S, Damais C, Alouf JE, Parant M (1988) Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med 167:752-761.
6. Miethke T, Wahl C, Hegg K, Echtenager B, Krammer PH, Wagner H (1992) T-cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175:91-98.
7. See RH, Chow AW (1992) Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect Immun 60: 3456-3459.
8. Muller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM (1994) Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci and lipopolysaccharide. Infect Immun 62:4915-4921.
9. Bayston K, Tomlinson M, Cohen J. (1992) In-vitro stimulation of TNF-α from human whole blood by cell-free supernatants of Gram-positive bacteria Cytokine 4:397-402.
10. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62:2715-2721.
11. Facklam RR, Washington JA (1991) Streptococcus and related catalase-negative Gram-positive cocci. In Balows A, Hausler WJ, Hermann K, Isenberg HD, Shadomy HJ (eds). Manual of Clinical Microbiology, 5th edition. American Society for Microbiology, pp 238-257.
12. Young SEG (1987) Aetiology and epidemiology of infective endocarditis in England and Wales. J Antimicrob Chemother 20 (Supp. A):7-14.
13. Everett ED, Herschmann GV (1977) Transient bacteremia and endocarditis prophylaxis. Medicine 56:61-77.
14. Sriskandan S, Soto A, Evans TE, Cohen J (1995) Viridans streptococcal bacteraemia: a clinical survey. Q J Med 88:415-420.
15. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG (1983). Septicemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet, 2: 1452-1454.
16. Bochud PY, Calandra T, Francioli P (1994) Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 97:256-264.
17. Bochud PY, Eggiman Ph, Calandra Th, Van Melle G, Sahhafi L, Francioli P (1993) Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 18:25-31.
18. Donnelly JP, Dompeling E, Meis JF, De Pauw BE (1995) Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis. Clin Infect Dis 20:469-470.
19. Martino R, Subirá M, Manteiga R, Badell I, Argilés B, Sureda A, Brunet S. (1995). Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: Comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation. Clin Infect Dis 20:476-477.
20. McWhinney PHM, Gillespie SH, Kibbler CC, Hoffbrand AV, Prentice HG, Streptococcus mitis and ARDS in neutropenic patients. Lancet 337:429
21. Fast DJ, Schlievert PM, Nelson RD (1989). Toxic shock syndrome-associated staphylococcal and streptococcal pytogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 57:291-294
22. Abe J, Forrester T, Nakahara T, Lafferty JA, Kotzin BL, Leung DYM (1991) Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol. 146: 3737-3750.
23. Hackett SP, Stevens DL (1993) Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J Infect Dis 168:232-235.
24. Kotzin BL, Leung DY, Kappler J, Marrack P (1993). Superantigens and their potential role in human disease. Adv Immunol. 54:99-166.
25. Hack CE, Hart M, Strack van Schijndel JM, Anke Eerenberg JM, Nuijens JH, Thijs LG, Aarden LA (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835-2842.
26. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon J-M (1994) Circulating interleukin 8 concentration in patients with multiple organ failure of septic and non septic origin. Crit Care Med 22:673-679.
27. Ognibene FP, Martin SE, Parker MM et al. (1986) Adult respiratory distress syndrome in patients with severe neutropenia. NEJM 315:547-551.
28. Watanakunakorn C, Pantelakis J (1993) Alpha-hemolytic streptococcal bacteremia: a review of 203 episodes during 1980-1991. Scand J Infect Dis 25:403-408.
29. Hardie JM (1986) Oral streptococci. In Sneath PHA (ed). Bergey's Manual for Systematic Bacteriology. Williams & Wilkins Inc, Baltimore pp 1054-1063.
30. Donnelly JP (1993) In: Viridans streptococci and allogeneic bone marrow transplant recipients. Current Medical Literature, London.
31. Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14:1202-1207.
32. Takada H, Kawabata Y, Tamura M, Matsushita K, Igarashi H, Ohkuni H, Todome Y, Uchiyama T, Kotani S (1993) Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun 61:5252-5260.
33. Okhuni H, Todome Y, Mizuse M, Ohtani N, Suzuki H, Igarashi H, Hashimoto Y, Ezaki T, Harada K, Imada Y, Ohkawa S, Kotani S (1994) Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease. J Med Microbiol 39:352-362
34. Matsushita K, Fujimaki W, Kato H, Uchiyama T, Igarashi H, Ohkuni H, Nagaoka S, Kawagoe M, Kotani S, Takada H (1995) Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect Immun 63:785-793.